Also, in this study HER2 overexpressing patients with upregulated p27Kip1, benefit significantly from antibody therapy indicating a prognostic value of this protein in HT patients, which is in agreement with other reports [55,56]. The gene discussed is CDKN1B; the disease is hematocrit.